BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3416562)

  • 1. Zinc status in inflammatory bowel disease.
    Ainley CC; Cason J; Carlsson LK; Slavin BM; Thompson RP
    Clin Sci (Lond); 1988 Sep; 75(3):277-83. PubMed ID: 3416562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum selenium, copper, and zinc concentrations in Crohn's disease and ulcerative colitis.
    Ringstad J; Kildebo S; Thomassen Y
    Scand J Gastroenterol; 1993 Jul; 28(7):605-8. PubMed ID: 8362213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum nitrate levels in ulcerative colitis and Crohn's disease.
    Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
    Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphonuclear leucocytes in Crohn's disease and ulcerative proctocolitis: association between enhanced adherence to nylon fibre and disease variables.
    Cason J; Ainley CC; Wolstencroft RA; Thompson RP
    J Clin Pathol; 1988 Mar; 41(3):241-6. PubMed ID: 3360954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum zinc and taste acuity in Tel-Aviv patients with inflammatory bowel disease.
    Tiomny E; Horwitz C; Graff E; Rozen P; Gilat T
    Am J Gastroenterol; 1982 Feb; 77(2):101-4. PubMed ID: 7072676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
    Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion molecules in inflammatory bowel disease.
    Jones SC; Banks RE; Haidar A; Gearing AJ; Hemingway IK; Ibbotson SH; Dixon MF; Axon AT
    Gut; 1995 May; 36(5):724-30. PubMed ID: 7541009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma viscosity in inflammatory bowel disease.
    Lobo AJ; Jones SC; Juby LD; Axon AT
    J Clin Pathol; 1992 Jan; 45(1):54-7. PubMed ID: 1740516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis.
    Mahida YR; Kurlac L; Gallagher A; Hawkey CJ
    Gut; 1991 Dec; 32(12):1531-4. PubMed ID: 1773961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Molecular Mediators of Inflammation Differentiate Between Crohn's Disease and Ulcerative Colitis, Implicating Threshold Levels of IL-10 and Relative Ratios of Pro-inflammatory Cytokines in Therapy.
    Kiernan MG; Coffey JC; Sahebally SM; Tibbitts P; Lyons EM; O'leary E; Owolabi F; Dunne CP
    J Crohns Colitis; 2020 Jan; 14(1):118-129. PubMed ID: 31241755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between trace elements, sugar consumption, and taste in Crohn's disease.
    Penny WJ; Mayberry JF; Aggett PJ; Gilbert JO; Newcombe RG; Rhodes J
    Gut; 1983 Apr; 24(4):288-92. PubMed ID: 6832625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interleukin-8 is an important inflammatory mediator in hemorrhagic rectocolitis and Crohn disease].
    Reimund JM; Duclos B; Dumont S; Muller C; Baumann R; Poindron P
    Gastroenterol Clin Biol; 1997; 21(2):131-7. PubMed ID: 9161479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content.
    Verspaget HW; Peña AS; Weterman IT; Lamers CB
    Gut; 1988 Feb; 29(2):223-8. PubMed ID: 2831119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease of different disease activities.
    Philipsen EK; Bondesen S; Andersen J; Larsen S
    Scand J Gastroenterol; 1995 Jan; 30(1):50-3. PubMed ID: 7701250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease.
    Kjeldsen J; Lassen JF; Brandslund I; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol; 1998 Jun; 33(6):637-43. PubMed ID: 9669637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiol methyltransferase activity in inflammatory bowel disease.
    Roediger WE; Babidge WJ
    Gut; 2000 Aug; 47(2):206-10. PubMed ID: 10896911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme in Crohn's disease and ulcerative colitis.
    Silverstein E; Fierst SM; Simon MR; Weinstock JV; Friedland J
    Am J Clin Pathol; 1981 Feb; 75(2):175-8. PubMed ID: 6258421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
    Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
    J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin G subclass distribution of anti-endothelial cell antibodies (AECA) in patients with ulcerative colitis or Crohn's disease.
    Aldebert D; Masy E; Reumaux D; Lion G; Colombel JF; Duthilleul P
    Dig Dis Sci; 1997 Nov; 42(11):2350-5. PubMed ID: 9398816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.